FDA
-
-
-
-
-
-
-
Bicycle Therapeutics plans dose selection update in first quarter 2026
-
-
-
-
-
-
-
Bicycle Therapeutics Announces Updated Topline Zelenectide Pevedotin Data and Highlights 2025 Strategic Priorities and Milestones
-
-
-
-
-
-
-
Bicycle Therapeutics Provides Data Updates for Three Clinical Programs and Strategy Overview at First R&D Day
-
-
-
-
-
-
-
Bicycle Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
ORION BIOTECHNOLOGY WELCOMES NEW MEMBERS OF SCIENTIFIC ADVISORY BOARD
-
327,801 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

